A Randomized, Open-Label, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Zolpidem Modified Release (MR) in Patients With Primary Insomnia.
Phase of Trial: Phase IV
Latest Information Update: 05 Oct 2011
At a glance
- Drugs Estazolam; Zolpidem
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 05 Oct 2011 Actual end date (November 2010) added as reported by ClinicalTrials.gov.
- 05 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 Nov 2010 Planned End Date changed from 1 Dec 2010 to 1 Mar 2011 as reported by ClinicalTrials.gov.